Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 1308 results found. Search for [ Drugs ]

Results 1 to 21 of 1308
E Kumar Sharma
New Delhi, July 18, 2018
Those within the pharma industry see a couple of messages coming across from the movie.


Mudit Kapoor
July 11, 2018
Before you select your insurance policy, go through these 10 situations that can put your insurance claim in jeopardy.


BusinessToday.in
New Delhi, July 10, 2018
China agrees to cut tariffs on Indian cancer drugsChina said on Monday it had reached an agreement with India to reduce tariffs and increase imports of Indian medicines, particularly anti-cancer drugs. The decision was part of its efforts to broaden trade relations amid its on-going spat with the United States. Both India and China slashed import tariffs of a range of products starting July 1, following the fourth round of negotiations under the Asia Pacific Trade Agreement (APTA), which also includes Bangladesh, Laos, South Korea and Sri Lanka.Income Tax dept sells Cairn Energy shares in Vedanta for $216 millionCairn Energy said it would write down the value of its investment in Vedanta Ltd after Indian tax authorities sold $216 million worth of its shares in the Indian mining company to recover a part of Rs 10,247-crore demanded as retrospective tax. The UK company said it still holds about 3 per cent in Vedanta Ltd after the sale, while warning that it was possible that the Indian tax department might make further sales.Department of Telecom conditionally approves Idea-Vodafone merger dealThe Department of Telecom (DoT) gave its nod to the Vodafone India-Idea Cellular deal to form the biggest telecom entity in India, but with some riders. An official told PTI that DoT has cleared the Vodafone-Idea merger. They will have to meet conditions for final approval. Earlier, it was reported the DoT was looking to raise a fresh demand of around Rs 4,700 crore ahead of the merger deal between Vodafone India and Idea Cellular over one-time spectrum charges on Vodafone.Mark Zuckerberg overtakes Warren Buffet to emerge world's third-richest man with $81.6 bn net worthFacebook's stock has not only recovered from the hammering it took in the wake of the Cambridge Analytica privacy scandal earlier this year, but spiked 2.4 per cent to hit an all-time high on Friday. And in the bargain, it has propelled its co-founder and CEO Mark Zuckerberg into the Top 3 list of billionaires. He is now the world's third-richest man after Amazon's Jeff Bezos and Microsoft co-founder Bill Gates.Malaysia's IHH Healthcare Berhad outbids TPG-Manipal in the battle for Fortis: ReportIn its second round of bidding, cash-strapped Fortis Healthcare received only two binding bids, from Malaysia's IHH Healthcare Berhad and TPG-backed Manipal Health Enterprises Ltd. And the buzz is that the former has an edge over FHL's earliest suitor. According to Mint, IHH is likely to acquire control of India's second-largest private hospital chain with a binding offer for a stake of at least 51 per cent for Rs 4,700-5,400 crore.Yahoo Japan buys back $2 billion of shares in three-way deal with SoftBank, AltabaYahoo Japan Corp is buying back around $2 billion worth of its shares from SoftBank Group Corp as part of a three-way deal with its top shareholders, U.S. investment firm Altaba Inc and SoftBank.The deal will see Altaba, which was formerly the internet giant Yahoo! Inc, sell down its stake in Yahoo Japan by around $2 billion and SoftBank raise its stake slightly in Yahoo Japan to around 48 percent.


Ananth Krishnan
July 10, 2018
India has particularly pressed China to open up its market for pharmaceuticals. There is widespread demand in China for Indian anticancer drugs which are often one-tenth the cost of the Western drugs that are available in China.


E. Kumar Sharma
New Delhi, July 9, 2018
Signs and symptoms of thyroid disorders can be subtle and often overlap with other health issues.


PB Jayakumar
New Delhi, June 28, 2018
Enbrel had global brand sales of approximately $11.6 billion for the 12 months ending December 31, 2017, according to IQVIA.


BusinessToday.In
June 26, 2018
Nestle, Danone and Hindustan Unilever (HUL), among other firms, are reportedly also in the race for GlaxoSmithKline Consumer Healthcare (GSKCH), whose product line-up includes Horlicks, Boost, and Maltova among others.


BusinessToday.In
June 26, 2018
The indirect tax department has reportedly sent tax notices to companies that transferred cash balance in their personal ledger account (PLA) to the transitional credit after the new tax regime, the Goods and Services Tax (GST), was rolled out in July last year.


Joe C. Mathew
New Delhi, June 25, 2018
Despite government initiatives, India's exports have remained below the 2013/14 levels. Exporters' GST problems and rising trade barriers suggest fast growth is unlikely to materialise.


E. Kumar Sharma
New Delhi, June 25, 2018
Know what thalassaemia is and learn how to avoid future complications.


BusinessToday.In,Joe C Mathew
New Delhi, June 20, 2018
World Intellectual Property Organisation (WIPO) is considering a proposal to permit countries to outsource their patent examination duties to patent offices of other countries.


BusinessToday.I0n
June 15, 2018
The stock has been gaining for the last eight days and has risen 20.08% in the period. It opened with a gain of 2.23% today. The stock has gained every month in the last seven months and has generated 20.02% returns in the period.


PTI
June 15, 2018



Joe C Mathew
New Delhi, June 14, 2018
In a concept note released on June 8, NITI Aayog said that the move is in line with the government plan to achieve the overall goal of affordable healthcare for all by making all critical and lifesaving medical devices available at affordable prices.


PTI
June 13, 2018



BusinessToday.In
June 11, 2018
\"The company has received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Bupropion Hydrochloride tablets,\" Alembic Pharmaceuticals said in a BSE filing.


E Kumar Sharma
New Delhi, June 8, 2018
The Indian pharma has recently seen a perceptible slide in the number of new products hitting the market. According to the analysts, slippages are more in select therapies and they attribute this to several reasons.


PTI
June 1, 2018



PTI
May 30, 2018



Khyati Dharamsi
New Delhi, May 28, 2018
Read the fine print to understand what all is covered, or you could be stuck with huge bills.


PAGES 1 OF 66  12345